Academic research institute
Appears in 1 story
Designed 21h10
Pancreatic cancer ignores nearly every approved immunotherapy, and the new KRAS inhibitors shrink tumors only until resistance emerges. A study published online this week in Cell pairs those inhibitors with a designer mimic of the immune signal IL-21 — and in mice, the combination cleared pancreatic tumors and kept them clear for months.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
